Skip to content

Clinical trials

Carcinoma, Ovarian Epithelial trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ovarian Epithelial Country / region: Italy Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20053
20061
20111
20163
20172
20181
20193
20205
20214
20225
20232
20242
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting12
Active, not recruiting6
Terminated5
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC6
AstraZeneca4
Fondazione Policlinico Universitario Agostino Gemelli IRCCS3
pharmaand GmbH3
Amgen2
ImmunoGen, Inc.2
Novartis Pharmaceuticals2
AbbVie1
Azienda USL Reggio Emilia - IRCCS1
Blue Earth Diagnostics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ovarian Epithelial46
Fallopian Tube Neoplasms21
Ovarian Neoplasms21
Neoplasms6
Triple Negative Breast Neoplasms4
Breast Neoplasms3
Carcinoma, Non-Small-Cell Lung3
Colorectal Neoplasms3
Endometrial Neoplasms3
Leukemia, Myeloid, Acute3

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.